Serum Institute of India (SII) commenced exporting the 'R21/Matrix-M' malaria vaccine to Africa in collaboration with the University of Oxford and Novavax. The initial shipment, directed to the Central African Republic, is part of efforts to combat malaria in endemic regions, with further doses earmarked for South Sudan and the Democratic Republic of Congo.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.